Hurlburt Elizabeth 4
4 · CorMedix Inc. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Hurlburt Elizabeth
Chief Operating Officer
Transactions
- Sale
Common Stock
2025-09-09$13.51/sh−12,876$173,955→ 176,990 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-09-09−12,876→ 41,121 totalExercise: $1.45Exp: 2028-03-19→ Common Stock (12,876 underlying) - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-09-11−41,121→ 0 totalExercise: $1.45Exp: 2028-03-19→ Common Stock (41,121 underlying) - Exercise/Conversion
Common Stock
2025-09-09$1.45/sh+12,876$18,670→ 189,866 total - Exercise/Conversion
Common Stock
2025-09-11$1.45/sh+41,121$59,625→ 218,111 total - Sale
Common Stock
2025-09-11$13.08/sh−41,121$537,863→ 176,990 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $13.50 to $13.61. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $12.98 to $13.17. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones.